Niosomal drug delivery systems for ocular disease-recent advances and future prospects
Open accessThe DOI matches its Crossref record; 124 of the 126 references it cites were found in a registry or an index.
Abstract
The eye is a complex organ consisting of several protective barriers and particular defense mechanisms. Since this organ is exposed to various infections, genetic disorders, and visual impairments it is essential to provide necessary drugs through the appropriate delivery routes and vehicles. The topical route of administration, as the most commonly used approach, maybe inefficient due to low drug bioavailability. New generation safe, effective, and targeted drug delivery systems based on nanocarriers have the capability to circumvent limitations associated with the complex anatomy of the eye. Nanotechnology, through various nanoparticles like niosomes, liposomes, micelles, dendrimers, and different polymeric vesicles play an active role in ophthalmology and ocular drug delivery systems. Niosomes, which are nano-vesicles composed of non-ionic surfactants, are emerging nanocarriers in drug delivery applications due to their solution/storage stability and cost-effectiveness. Additionally, they are biocompatible, biodegradable, flexible in structure, and suitable for loading both hydrophobic and hydrophilic drugs. These characteristics make niosomes promising nanocarriers in the treatment of ocular diseases. Hereby, we review niosome based drug delivery approaches in ophthalmology starting with different preparation methods of niosomes, drug loading/release mechanisms, characterization techniques of niosome nanocarriers and eventually successful applications in the treatment of ocular disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Niosomes, which are comprised of uncharged single-chain surfactant and cholesterol94,95 have also shown limited success potential as non-viral gene delivery systems96–101 due to improved transfection efficiency, biocompatibility, and cellular uptake, in addition to effects on intracellular trafficking.102”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [97]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Higuchi, T. (1963) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600521210 · Cited by 4,884
Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020057 · Cited by 4,832
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918 · cited 1×
“For ocular applications, particles should have narrow size distribution and small polydispersity index values as lower PDI values are better for the uptake of nanoparticles and posterior internalization [97].”
BackgroundSzoka, F., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,323
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Non-ionic surfactant based vesicles (niosomes) in drug delivery
Uchegbu, I. F., & Vyas, S. P. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00169-0 · Cited by 1,020
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Nano-niosomes as nanoscale drug delivery systems: An illustrated review
Moghassemi, S., & Hadjizadeh, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.015 · Cited by 797
Niosome: A future of targeted drug delivery systems
Kuotsu, K., Karim, K., Mandal, A., Biswas, N., Guha, A., Chatterjee, S., & Behera, M. (2010) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/0110-5558.76435 · Cited by 626
Update on the Management of Infectious Keratitis
Austin, A., Lietman, T., & Rose-Nussbaumer, J. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.05.012 · Cited by 613
Conjunctivitis: A Systematic Review of Diagnosis and Treatment
Azari, A. A., & Barney, N. P. (2013) · JAMA · doi:10.1001/jama.2013.280318 · Cited by 597
Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
Ge, X., Wei, M., He, S., & Yuan, W.-E. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020055 · Cited by 578
Niosomes from 80s to present: The state of the art
Marianecci, C., Di Marzio, L., Rinaldi, F., Celia, C., Paolino, D., Alhaique, F., Esposito, S., & Carafa, M. (2014) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2013.11.018 · Cited by 536
Dehydration-Rehydration Vesicles: A Simple Method for High Yield Drug Entrapment in Liposomes
Kirby, C., & Gregoriadis, G. (1984) · Nature Biotechnology · doi:10.1038/nbt1184-979 · Cited by 532
Non-ionic surfactant vesicles (niosomes): Physical and pharmaceutical chemistry
Uchegbu, I. F., & Florence, A. T. (1995) · Advances in Colloid and Interface Science · doi:10.1016/0001-8686(95)00242-i · Cited by 467
Contact lenses and other risk factors in microbial keratitis
Dart, J. K. G., Stapleton, F., Minassian, D., & Dart, J. K. G. (1991) · The Lancet · doi:10.1016/0140-6736(91)91231-i · Cited by 425
Glaucoma as a neurodegenerative disease
Gupta, N., & Yücel, Y. H. (2007) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e3280895aea · Cited by 422
Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient
Fritze, A., Hens, F., Kimpfler, A., Schubert, R., & Peschka-Süss, R. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.028 · Cited by 416
Niosomes: A Controlled and Novel Drug Delivery System
Rajera, R., Nagpal, K., Singh, S. K., & Mishra, D. N. (2011) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.34.945 · Cited by 415
Current and future ophthalmic drug delivery systems
del Amo, E. M., & Urtti, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.002 · Cited by 414
Niosomes: Novel sustained release nonionic stable vesicular systems — An overview
Mahale, N. B., Thakkar, P. D., Mali, R. G., Walunj, D. R., & Chaudhari, S. R. (2012) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2012.08.002 · Cited by 383
Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol
Manosroi, A., Wongtrakul, P., Manosroi, J., Sakai, H., Sugawara, F., Yuasa, M., & Abe, M. (2003) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(03)00080-8 · Cited by 379
Nanotechnology-based strategies for treatment of ocular disease
Weng, Y., Liu, J., Jin, S., Guo, W., Liang, X., & Hu, Z. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.09.001 · Cited by 375
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery
Balakrishnan, P., Shanmugam, S., Lee, W. S., Lee, W. M., Kim, J. O., Oh, D. H., Kim, D.-D., Kim, J. S., Yoo, B. K., Choi, H.-G., et al. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.020 · Cited by 366
Studies on a high encapsulation of colchicine by a niosome system
Hao, Y., Zhao, F., Li, N., Yang, Y., & Li, K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00301-0 · Cited by 365
Guinedi, A. S., Mortada, N. D., Mansour, S., & Hathout, R. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.023 · Cited by 355
Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery
Abdelbary, G., & El-gendy, N. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9105-1 · Cited by 333
Proniosomes: A Novel Drug Carrier Preparation
Hu, C., & Rhodes, D. G. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00122-2 · Cited by 298
Srinivasan, M. (2004) · Current Opinion in Ophthalmology · doi:10.1097/00055735-200408000-00008 · Cited by 289
Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier
Gharbavi, M., Amani, J., Kheiri-Manjili, H., Danafar, H., & Sharafi, A. (2018) · Advances in Pharmacological Sciences · doi:10.1155/2018/6847971 · Cited by 287
Allergic conjunctivitis: a comprehensive review of the literature
La Rosa, M., Lionetti, E., Reibaldi, M., Russo, A., Longo, A., Leonardi, S., Tomarchio, S., Avitabile, T., & Reibaldi, A. (2013) · Italian Journal of Pediatrics · doi:10.1186/1824-7288-39-18 · Cited by 283
Spanlastics—A novel nanovesicular carrier system for ocular delivery
Kakkar, S., & Kaur, I. P. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.027 · Cited by 267
Amoabediny, G., Haghiralsadat, F., Naderinezhad, S., Helder, M. N., Akhoundi Kharanaghi, E., Mohammadnejad Arough, J., & Zandieh-Doulabi, B. (2018) · International Journal of Polymeric Materials and Polymeric Biomaterials · doi:10.1080/00914037.2017.1332623 · Cited by 256
Subrizi, A., del Amo, E. M., Korzhikov-Vlakh, V., Tennikova, T., Ruponen, M., & Urtti, A. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.02.001 · Cited by 239
Pathogenesis of microbial keratitis
Lakhundi, S., Siddiqui, R., & Khan, N. A. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.12.013 · Cited by 235
Glaucoma ocular Alzheimer s disease
McKinnon, S. J. (2003) · Frontiers in Bioscience · doi:10.2741/1172 · Cited by 228
Aggarwal, D., & Kaur, I. P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.10.026 · Cited by 223
Willoughby, C. E., Ponzin, D., Ferrari, S., Lobo, A., Landau, K., & Omidi, Y. (2010) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2010.02363.x · Cited by 210
Dadashzadeh, S., Haeri, A., Daeihamed, M., Arzani, G., & Kaboutaraki, H. B. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s84703 · Cited by 203
Niosomes: A Novel Drug Delivery System
Chandu, V. P., Arunachalam, A., Jeganath, S., Yamini, K. R., & Tharangini, K. (2012) · International Journal of Novel Trends in Pharmaceutical Sciences · Cited by 195
Baillie, A. J., Coombs, G. H., Dolan, T. F., & Laurie, J. (1986) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1986.tb04623.x · Cited by 188
Abdelbary, A. A., Abd-Elsalam, W. H., & Al-mahallawi, A. M. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.006 · Cited by 188
Abdelkader, H., Ismail, S., Kamal, A., & Alany, R. G. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22422 · Cited by 169
Zeng, W., Li, Q., Wan, T. Y., Liu, C., Pan, W., Wu, Z., Zhang, G., Pan, J., Qin, M., Lin, Y., et al. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.01.014 · Cited by 166
A novel cationic niosome formulation for gene delivery to the retina
Puras, G., Mashal, M., Zárate, J., Agirre, M., Ojeda, E., Grijalvo, S., Eritja, R., Diaz-Tahoces, A., Martínez Navarrete, G., Avilés-Trigueros, M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.11.004 · Cited by 164
Controlled ocular drug delivery with nanomicelles
Vaishya, R. D., Khurana, V., Patel, S., & Mitra, A. K. (2014) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1272 · Cited by 162
Kamboj, S., Saini, V., & Bala, S. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/959741 · Cited by 161
Mannosylated niosomes as adjuvant–carrier system for oral genetic immunization against Hepatitis B
Jain, S., Singh, P., Mishra, V., & Vyas, S. P. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.04.002 · Cited by 153
Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits
Attia, I. A., El‐Gizawy, S. A., Fouda, M. A., & Donia, A. M. (2007) · AAPS PharmSciTech · doi:10.1208/pt0804106 · Cited by 146
A concise review on cancer treatment methods and delivery systems
Bidram, E., Esmaeili, Y., Ranji‐Burachaloo, H., Al-Zaubai, N., Zarrabi, A., Stewart, A. G., & Dunstan, D. E. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101350 · Cited by 140
Self-citationSustained Drug Release in Nanomedicine: A Long-Acting Nanocarrier-Based Formulation for Glaucoma
Natarajan, J. V., Darwitan, A., Barathi, V. A., Ang, M., Htoon, H. M., Boey, F., Tam, K. C., Wong, T. T. L., & Venkatraman, S. S. (2014) · ACS Nano · doi:10.1021/nn4046024 · Cited by 135
A review on novel vesicular drug delivery: proniosomes
Ramesh, Y. V., Jakki, S. L., Natarajan, J., & Kuppusamy, G. (2013) · Drug Delivery · doi:10.3109/10717544.2013.841783 · Cited by 130
Formulation of resveratrol entrapped niosomes for topical use
Pando, D., Matos, M., Gutiérrez, G., & Pazos, C. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2015.02.037 · Cited by 124
Rodrigues, G. A., Lutz, D., Shen, J., Yuan, X., Shen, H., Cunningham, J., & Rivers, H. M. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2519-x · Cited by 124
Micropulse laser for the treatment of glaucoma: A literature review
Ma, A., Yu, S. W. Y., & Wong, J. K. W. (2019) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2019.01.001 · Cited by 122
Development of a topical niosomal preparation of acetazolamide: preparation and evaluation
Aggarwal, D., Garg, A. B., & Kaur, I. P. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044896 · Cited by 121
Li, Q., Li, Z., Zeng, W., Ge, S., Lu, H., Wu, C., Li, G., Liang, D., & Xu, Y. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.05.020 · Cited by 119
Eldeeb, A. E., Salah, S., & Ghorab, M. M. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1609622 · Cited by 118
Light activated liposomes: Functionality and prospects in ocular drug delivery
Lajunen, T., Nurmi, R., Kontturi, L.-S., Viitala, L., Yliperttula, M. L., Murtomäki, L. S., & Urtti, A. O. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.024 · Cited by 116
Cholinergic nervous system and glaucoma: From basic science to clinical applications
Faiq, M. A., Wollstein, G., Schuman, J. S., & Chan, K. C. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.06.003 · Cited by 116
Farmoudeh, A., Akbari, J., Saeedi, M., Ghasemi, M., Asemi, N., & Nokhodchi, A. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00715-6 · Cited by 113
Gaafar, P. M. E., Abdallah, O. Y., Farid, R. M., & Abdelkader, H. (2014) · Journal of Liposome Research · doi:10.3109/08982104.2014.881850 · Cited by 108
Elmotasem, H., & Awad, G. E. A. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.09.003 · Cited by 107
Preparation and characterization of niosomes containing rifampicin for lung targeting
Jain, C. P., & Vyas, S. P. (1995) · Journal of Microencapsulation · doi:10.3109/02652049509087252 · Cited by 102
Kaur, I. P., Rana, C., Singh, M., Bhushan, S., Singh, H., & Kakkar, S. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2011.0176 · Cited by 102
Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system
Gugleva, V., Titeva, S., Rangelov, S., & Momekova, D. B. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.06.022 · Cited by 101
Mortazavi, S. M., Mohammadabadi, M., Khosravi‐Darani, K., & Mozafari, M. R. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.02.005 · Cited by 97
Ciprofloxacin nano-niosomes for targeting intracellular infections: an in vitro evaluation
Akbari, V., Abedi, D., Pardakhty, A., & Sadeghi‐Aliabadi, H. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1556-y · Cited by 95
Application of nanoparticles in ocular drug delivery systems
Omerović, N., & Vranić, E. (2019) · Health and Technology · doi:10.1007/s12553-019-00381-w · Cited by 93
Effect of size and lipid composition on the pharmacokinetics of intravitreal liposomes.
Barza, M. J., Stuart, M., & Szoka, F. C. (1987) · PubMed · Cited by 91
Characteristics of niosomes prepared by supercritical carbon dioxide (scCO2) fluid
Manosroi, A., Chutoprapat, R., Abe, M., & Manosroi, J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.10.013 · Cited by 90
Abdelkader, H., Ismail, S., Hussein, A. K., Wu, Z., Al‐Kassas, R., & Alany, R. G. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.063 · Cited by 90
Hydroxychloroquine niosomes: A new trend in topical management of oral lichen planus
Bendas, E. R., Abdullah, H., El-Komy, M. H. M., & Kassem, M. A. A. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.10.042 · Cited by 87
Nonionic Surfactant Vesicles in Ocular Delivery: Innovative Approaches and Perspectives
Sahoo, R. K., Biswas, N., Guha, A., Sahoo, N., & Kuotsu, K. (2014) · BioMed Research International · doi:10.1155/2014/263604 · Cited by 86
Liu, Y., Wang, Y., Yang, J., Zhang, H., & Gan, L. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.018 · Cited by 85
Formulation and Characterization of Bovine Serum Albumin-Loaded Niosome
Moghassemi, S., Hadjizadeh, A., & Omidfar, K. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-016-0487-1 · Cited by 83
Kaur, I. P., Aggarwal, D., Singh, H., & Kakkar, S. (2010) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-010-1383-0 · Cited by 82
Talsma, H., van Steenbergen, M. J., Borchert, J. C. H., & Crommelin, D. J. A. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830303 · Cited by 82
Fetih, G. N. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.06.002 · Cited by 82
Glaucoma is an autoimmune disease
Geyer, O., & Levo, Y. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102535 · Cited by 82
Gene therapy for retinal disease
McClements, M. E., & MacLaren, R. E. (2013) · Translational Research · doi:10.1016/j.trsl.2012.12.007 · Cited by 80 · cited 3×
“Inherited Retinal Diseases (IRD) are heterogeneous disorders, resulting in retinal degeneration.”
BackgroundInfluentialFitzgerald, P. B., Hadgraft, J., Kreuter, J., & WILSON, C. G. (1987) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(87)90050-0 · Cited by 80
Allam, A., El‐Mokhtar, M. A., & Elsabahy, M. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13106 · Cited by 79
Zubairu, Y., Negi, L. M., Iqbal, Z., & Talegaonkar, S. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2015.02.001 · Cited by 77
Rapid Microfluidic Preparation of Niosomes for Targeted Drug Delivery
Seleci, D. A., Maurer, V., Stahl, F., Scheper, T. H., & Garnweitner, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194696 · Cited by 77
Alfonso, S. A., Fawley, J. D., & Lu, X. A. (2015) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2015.05.001 · Cited by 76
Bourcier, T., Sauer, A., Dory, A., Denis, J., & Sabou, M. (2017) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2017.08.001 · Cited by 75
Ojeda, E., Puras, G., Agirre, M., Zarate, J., Grijalvo, S., Eritja, R., Martinez-Navarrete, G., Soto-Sánchez, C., Diaz-Tahoces, A., Aviles-Trigueros, M., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.017 · Cited by 74
Mashal, M., Attia, N., Puras, G., Martínez-Navarrete, G., Fernández, E., & Pedraz, J. L. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.386 · Cited by 74
Khalil, R. M., Abdelbary, G. A., Basha, M., Awad, G. E. A., & el-Hashemy, H. A. (2017) · Journal of Liposome Research · doi:10.1080/08982104.2016.1191022 · Cited by 68
Paradkar, M. U., & Parmar, M. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.03.005 · Cited by 66
Uchegbu, I. F., Double, J. A., Kèlland, L. R., Turton, J. A., & Florence, A. T. (1996) · Journal of drug targeting · doi:10.3109/10611869608996831 · Cited by 65
Sayed, M. M. E., Hussein, A. K., Sarhan, H. A., & Mansour, H. F. (2016) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2016.1272120 · Cited by 65
Abdelkader, H., Ismail, S., Kamal, A., & Alany, R. G. (2010) · Die Pharmazie · doi:10.31083/ph.2010.0138 · Cited by 62
Dorati, R., DeTrizio, A., Spalla, M., Migliavacca, R., Pagani, L., Pisani, S., Chiesa, E., Conti, B., Modena, T., & Genta, I. (2018) · Nanomaterials · doi:10.3390/nano8010037 · Cited by 62
Maiti, S., Paul, S., Mondol, R., Ray, S., & Sa, B. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9643-9 · Cited by 60
Mashal, M., Attia, N., Martínez-Navarrete, G., Soto-Sánchez, C., Fernández, E., Grijalvo, S., Eritja, R., Puras, G., & Pedraz, J. L. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.010 · Cited by 58
Treatment of Viral Conjunctivitis with Antiviral Drugs
Skevaki, C. L., Galani, I. E., Pararas, M. V., Giannopoulou, K., & Tsakris, A. (2011) · Drugs · doi:10.2165/11585330-000000000-00000 · Cited by 55
Ojeda, E., Puras, G., Agirre, M., Zárate, J., Grijalvo, S., Pons, R., Eritja, R., Martinez-Navarrete, G., Soto-Sanchez, C., Fernández, E., et al. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob02087a · Cited by 54
Verma, A., Sharma, G., Jain, A., Tiwari, A., Saraf, S., Panda, P. K., Katare, O. P., & Jain, S. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.04.118 · Cited by 52
Rinaldi, F., Favero, E. D., Möller, J., Hanieh, P. N., Passeri, D., Rossi, M., Angeloni, L., Venditti, I., Marianecci, C., Carafa, M., et al. (2019) · Nanomaterials · doi:10.3390/nano9081177 · Cited by 52
Abdelbary, A., Salem, H. F., Khallaf, R. A., & Ali, A. M. A. (2016) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1219916 · Cited by 51
Development and investigation of timolol maleate niosomal formulations for the treatment of glaucoma
Ramadan, A. A., El-Adawy, S. A., El-Enin, A. S. M. A., & Hussein, Z. M. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00427-1 · Cited by 51
A gamma scintigraphic evaluation of the precorneal residence of liposomal formulations in the rabbit
Fitzgerald, P. B., Hadgraft, J., & WILSON, C. G. (1987) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1987.tb03428.x · Cited by 47
Prabhu, P. P., Kumar, R. N., Koland, M., Harish, N. M., Vijayanarayan, K., Dhondge, G., & Charyulu, R. N. (2010) · Journal of Young Pharmacists · doi:10.4103/0975-1483.71623 · Cited by 47
Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems
Juliana, F. R., Kesse, S., Boakye‐Yiadom, K. O., Veroniaina, H., Wang, H., & Sun, M. (2019) · Molecules · doi:10.3390/molecules24203805 · Cited by 47
Shukr, M. H. (2016) · Journal of Microencapsulation · doi:10.3109/02652048.2015.1128489 · Cited by 45
Arsenic Trioxide Liposomes: Encapsulation Efficiency and In Vitro Stability
Kallinteri, P., Fatouros, D. G., Klepetsanis, P. G., & Antimisiaris, S. G. (2004) · Journal of Liposome Research · doi:10.1081/lpr-120039661 · Cited by 43
Tagalakis, A. D., Madaan, S., Larsen, S. D., Neubig, R. R., Khaw, P. T., Rodrigues, I. A. S., Goyal, S., Lim, K. S., & Yu‐Wai‐Man, C. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0425-3 · Cited by 43
Villate-Beitia, I., Gallego, I., Martínez-Navarrete, G., Zárate, J., López-Méndez, T., Soto-Sánchez, C., Santos-Vizcaíno, E., Puras, G., Fernández, E., & Pedraz, J. L. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.035 · Cited by 42
Potential Use of Niosomal Hydrogel as an Ocular Delivery System for Atenolol
Hashim, I. I. A., El-Dahan, M. S., Yusif, R. M., Abd-Elgawad, A.-E. H., & Arima, H. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00724 · Cited by 40
Design and Evaluation of Ocular Controlled Delivery System for Diclofenac Sodium.
Jafariazar, Z., Jamalinia, N., Ghorbani‐Bidkorbeh, F., & Mortazavi, S. A. (2015) · PubMed Central · Cited by 29
Sharaf, M. G., Çetinel, S., Heckler, L. V., Damji, K. F., Unsworth, L. D., & Montemagno, C. D. (2014) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000059 · Cited by 29
Dorzolamide Loaded Niosomal Vesicles: Comparison of Passive and Remote Loading Methods.
Dehaghi, M. H., Haeri, A., Keshvari, H., Abbasian, Z., & Dadashzadeh, S. (2017) · Europe PMC (PubMed Central) · Cited by 29
Advancements in Understanding Immunogenicity of Biotherapeutics in the Intraocular Space
Wakshull, E., Quarmby, V. E., Mahler, H., Rivers, H. M., Jere, D., Ramos, M. F., Szczesny, P. J., Bechtold-Peters, K., Masli, S., & Gupta, S. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0128-y · Cited by 29
Nanotechnology Applications for Glaucoma
Çetinel, S., & Montemagno, C. D. (2015) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000171 · Cited by 24
Mishra, J., Swain, J., & Mishra, A. K. (2018) · Physical Chemistry Chemical Physics · doi:10.1039/c8cp00492g · Cited by 22
Yasin, M. N., Hussain, S., Malik, F., Hameed, A., Sultan, T., Qureshi, F., Riaz, H., Perveen, G., & Wajid, A. (2012) · PubMed · Cited by 19
Remote Loading of Anthracyclines into Liposomes
Lewrick, F., & Süss, R. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-360-2_9 · Cited by 16
Akhtar, N., Singh, R. K., & Pathak, K. (2017) · Pharmaceutical and Biomedical Research · doi:10.18869/acadpub.pbr.3.1.22 · Cited by 16
Kaur, I. P., Mitra, A. K., & Aggarwal, D. (2007) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(07)50005-5 · Cited by 7
Formulation and Evaluation of Atorvastatin Calcium Niosomes
Sharma, Y., Kumar, K., & Padhy, S. K. (2016) · SSR Institute of International Journal of Life Sciences · doi:10.21276/ijlssr.2016.2.4.23 · Cited by 7
Research works printed but not linked: 3
- More V.V. Gilhotra R.M. Nitalikar M.M. Khule P.K. Niosomal Drug Delivery-A Comprehensive Review Asian J. Pharm. 2019 12 S1159 S1164
- Lakshmi P.K. Bhaskaran S. Phase II study of topical niosomal urea gel-an adjuvant in the treatment of psoriasis Int. J. Pharm. Sci. Rev. Res. 2011 7 1 7
- Biswas G.R. Majee S.B. Niosomes in ocular drug delivery Eur. J. Pharm. Med. Res. 2017 4 813 819
Cited by
Alkilani, A. Z., Nasereddin, J., Hamed, R., Nimrawi, S., Hussein, G., Abo-Zour, H., & Donnelly, R. F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061152 · Cited by 201
Current advances in niosomes applications for drug delivery and cancer treatment
Moammeri, A., Chegeni, M. M., Sahrayi, H., Ghafelehbashi, R., Memarzadeh, F., Mansouri, A., Akbarzadeh, I., Abtahi, M. S., Hejabi, F., & Ren, Q. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100837 · Cited by 195
Hyaluronic acid in ocular drug delivery
Zhang, X., Wei, D., Xu, Y., & Zhu, Q. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118006 · Cited by 196
Synthesis and Potential Applications of Lipid Nanoparticles in Medicine
Musielak, E., Feliczak-Guzik, A., & Nowak, I. (2022) · Materials · doi:10.3390/ma15020682 · Cited by 159
Nanomaterials as Nanofertilizers and Nanopesticides: An Overview
Okey‐Onyesolu, C. F., Hassanisaadi, M., Bilal, M., Barani, M., Rahdar, A., Iqbal, J., & Kyzas, G. Z. (2021) · ChemistrySelect · doi:10.1002/slct.202102379 · Cited by 178
Metadata
- Authors
- Durak, S., Esmaeili Rad, M., Alp Yetisgin, A., Eda Sutova, H., Kutlu, O., Cetinel, S., & Zarrabi, A.
- Affiliations
- Sabancı Üniversitesi (TR)
- Nanotechnology Research and Application Center (SUNUM), Sabanci University, Istanbul 34956, Turkey
- Corresponding author
- Zarrabi, Ali
- Venue
- Nanomaterials
- Publisher
- MDPI AG
- Published
- 2020-06-18
- Volume
- 10
- Issue
- 6
- Pages
- 1191
- ISSN
- 2079-4991 (ISSN-L)
- PMC
- PMC7353242
- OpenAlex
- W3036547471
- Cited by
- 196
- References
- 126
- Citations by year
- 2026: 26 · 2025: 35 · 2024: 44 · 2023: 40 · 2022: 27 · 2021: 22 · 2020: 2
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nanomaterials (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Sabanci University (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- SUNUM (I.A.SN-19-00005 (S.C.) and I.A.SN-19-00001 (A.Z.))
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- niosomes, ocular drug delivery, nonionic surfactants, nanocarriers, eye diseases, drug loading and release, niosome characterization, topical ocular administration, drug bioavailability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.